Undifferentiated sarcoma: does it exist? A clinicopathologic study of 7 pediatric cases and review of literature

Human Pathology

Volumn 40, Issue 11, 2009, Pages 1600-1610

  Alaggio, Rita ^a   Bisogno, Gianni ^a   Rosato, Antonio ^a,b   Ninfo, Vito ^a   Coffin, Cheryl M ^c  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

Fibrosarcoma; Immunohistochemistry; RT PCR; Undifferentiated sarcoma

Indexed keywords

CD34 ANTIBODY; CD99 ANTIGEN; CYTOKERATIN; DESMIN; EPITHELIAL MEMBRANE ANTIGEN; MYOGENIC FACTOR; MYOGENIC FACTOR 4; NESTIN; PROTEIN S 100; SMOOTH MUSCLE ACTIN; STEM CELL FACTOR RECEPTOR; SURVIVIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADOLESCENT; ARM; ARTICLE; CANCER MORTALITY; CANCER SIZE; CANCER SURGERY; CHILD; CLINICAL ARTICLE; CYTOGENETICS; EWING SARCOMA; FEMALE; FIBROSARCOMA; FOLLOW UP; GENE TRANSLOCATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; MALE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; RHABDOMYOSARCOMA; SARCOMA; SCHOOL CHILD; SPINDLE CELL; STEM CELL; SYNOVIAL SARCOMA; TRUNK; TUMOR BIOPSY; UNDIFFERENTIATED SARCOMA;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; INFANT, NEWBORN; MALE; MICROTUBULE-ASSOCIATED PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SARCOMA; SOFT TISSUE NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 70349864887     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2009.04.013     Document Type: Article

References (35)

1. Hill A.D., O'Sullivan M.J., Zhu X., et al. Practical application of molecular genetic testing as an aid to the surgical pathologic diagnosis of sarcomas. A prospective study. Am J Surg Pathol 26 (2002) 965-977
2. Hoot A.C., Russo P., Judkins A.R., et al. Immunohistochemical analysis of hSNF5/INI1 distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumors. Am J Surg Pathol 28 (2004) 1485-1491
3. Pawel B.R., Hamoudi A.B., Asmar L., et al. Undifferentiated sarcomas of children: pathology and clinical behavior-an Intergroup Rhabdomyosarcoma Study. Med Pediatr Oncol 29 (1997) 170-180
4. Gonzales-Crussi F., and Black-Schaffer S. Rhabdomyosarcoma of infancy and childhood. Problems of morphologic classification. Am J Surg Pathol 3 (1979) 157-171
5. Newton W.A., Gehan E.A., Webber B.L., et al. Classification of rhabdomyosarcoma and related sarcomas: pathologic aspects and proposal for a new classification-an Intergroup Rhabdomyosarcoma Study. Cancer 76 (1995) 1073-1085
6. Newton Jr. W.A., Soule E.H., Hamoudi A.B., et al. Histopathology of childhood sarcomas, Intergroup Rhabdomyosarcoma Studies I and II: clinicopathologic correlation. J Clin Oncol 6 (1988) 67-75
7. Somers G.R., Gupta A.A., Doria A.S., et al. Pediatric undifferentiated sarcoma of the soft tissues: a clinicopathologic study. Pediatr Dev Pathol 9 (2006) 132-142
8. Orbach D., Rey A., Oberlin O., et al. Soft tissue sarcoma or malignant mesenchymal tumors in the first year of life: experience of the International Society of Pediatric Oncology (SIOP) Malignant Mesenchymal Tumor Committee. J Clin Oncol 23 (2005) 4363-4367
9. Pappo A.S., Lyden E., Breitfeld P., et al. Two consecutive phase II window trials of irinotecan alone or in combination with vincristine for the treatment of metastatic rhabdomyosarcoma: the children's oncology group. J Clin Oncol 25 (2007) 362-369
10. Raney R.B., Anderson J.R., Barr F.G., et al. Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of Intergroup Rhabdomyosarcoma Study group experience and rationale for Intergroup Rhabdomyosarcoma Study V. J Ped Hematol Oncol 23 (2001) 215-220
11. Fletcher C.D.M., Krishnan Unni K., and Mertens F. Pathology & genetics. Tumours of soft tissue and bone (2002), IARC Press, Lyon (France)
12. Wang L., Bhargava R., Zheng T., et al. Undifferentiated small round cell sarcomas with rare EWS gene fusions. Identification of a novel EWS-SP3 fusion and of additional cases with the EWS-ETV1 and EWS-FEV fusions. J Mol Diagn 9 (2007) 498-550
13. Trojani M., Contesso G., Coindre J.M., et al. Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer 33 (1984) 37-42
14. Rosato A., Pivetta M., Parenti A., et al. Survivin in esophageal cancer: an accurate prognostic marker for squamous cell carcinoma but not adenocarcinoma. Int J Cancer 119 (2006) 1717-1722
15. Sebire N.J., Ramsay A.D., Levitt G., et al. Aberrant immunohistochemical expression in nonrhabdomyosarcoma soft tissue sarcomas of infancy: retrospective review of clinical material. Pediatr Dev Pathol 5 (2002) 579-586
16. Knezevich S.R., McFadden D.E., Tao W., Lim J.F., and Sorensen P.H. A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nat Genet 18 (1998) 184-187
17. Parham D.M. Appearances may be deceiving: does aggressive histology correlate with behavior of infantile sarcomas?. Pediatr Dev Pathol 5 (2002) 513-514
18. Coffin C.M., Jaszcz W., O'Shea P.A., and Dehner L.P. So-called congenital-infantile fibrosarcoma: does it exist and what is it?. Pediatr Pathol 14 (1994) 133-150
19. Alaggio R., Ninfo V., Rosolen A., and Coffin C.M. Primitive myxoid mesenchymal tumor of infancy: a clinicopathologic report of 6 cases. Am J Surg Pathol 30 (2006) 388-394
20. Billings S.D., Giblen G., and Fanburg-Smith J.C. Superficial low-grade fibromyxoid sarcoma (Evans tumor): a clinicopathologic analysis of 19 cases with a unique observation in the pediatric population. Am J Surg Pathol 29 (2005) 204-210
21. Weiss S.W., and Goldblum J.R. Fibrosarcoma. Enzinger and Weiss's soft tissue tumors. 5th ed. (2008), Mosby Elsevier, St. Louis (USA) 303-330
22. Lorenz K., Sicker M., Schmelzer E., et al. Multilineage differentiation potential of human dermal skin-derived fibroblasts. Exp Dermatol 17 (2008) 925-932
23. Wiese C., Rolletschek A., Kania G., et al. Nestin expression-a property of multi-lineage progenitor cells?. Cell Mol Life Sci 61 (2004) 2510-2522
24. Taubert H., Wurl P., Greither T., et al. Stem cell-associated genes are extremely poor prognostic factors for soft-tissue sarcoma patients. Oncogene 26 (2007) 7170-7174
25. Alaggio R., d'Amore E.S.G., Bisogno G., et al. Expression of survivin, livin and caspase 3 in pediatric malignant peripheral nerve sheath tumors. Mod Pathol 21 Suppl 1 (2008) 332A
26. Powell D.W., Mifflin R.C., Valentich J.D., et al. Myofibroblasts, I: paracrine cells important in health and disease. Am J Physiol Cell Physiol 46 (1999) 1-19
27. Wagner W., Wein F., Seckinger A., et al. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol 33 (2005) 1402-1416
28. Sartore S., Chiavegato A., Faggin E., et al. Contribution of adventitial fibroblasts to neointima formation and vascular remodeling: from innocent bystander to active participant. Circ Res 89 (2001) 1111-1121
29. Sell S. Cancer stem cells and differentiation therapy. Tumor Biol 27 (2006) 59-70
30. Carmeliet P., and Jain R.K. Angiogenesis in cancer and other diseases. Nature 407 (2000) 249-257
31. Millauer B., Wizigmann-Voos S., Schnurch H., et al. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72 (1993) 835-846
32. Shen R., Ye Y., Chen L., et al. Precancerous stem cells can serve as tumor vasculogenic progenitors. PLoS ONE 3 (2008) e1652
33. Ribatti D. The involvement of endothelial progenitor cells in tumor angiogenesis. J Cell Mol Med 8 (2004) 294-300
34. Selvarajah S., Yoshimoto M., Prasad M., et al. Characterization of trisomy 8 in pediatric undifferentiated sarcomas using advanced molecular cytogenetic techniques. Cancer Genet Cytogenet 174 (2007) 35-41
35. Plaat B.E., Molenaar W.M., Mastik M.F., et al. Computer assisted cytogenetic analysis of 51 malignant peripheral nerve sheath tumors: sporadic vs. neurofibromatosis-type-1 associated malignant schwannomas. Int I Cancer 83 (1999) 171-178